For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.
Scope of the Report:
This report focuses on the Anti-Suicide Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Anti-Suicide Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 4610 million US$ in 2023, from 3600 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Pfizer
- AstraZeneca plc
- Eli Lilly and Company
- Allergan plc
- GlaxoSmithKline plc
- Merck & Co., Inc
- H. Lundbeck A/S
- NeuroRx, Inc
- Johnson & Johnson
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Anti-Depressants and Anti-Anxiety Drugs
- Anti-Psychotic Drugs
- NMDA Antagonist
- Antibiotic Analog
Market Segment by Applications, can be divided into
- Hospitals
- Retail pharmacies
- Online pharmacies
There are 15 Chapters to deeply display the global Anti-Suicide Drugs market.
Chapter 1, to describe Anti-Suicide Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-Suicide Drugs, with sales, revenue, and price of Anti-Suicide Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Suicide Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-Suicide Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-Suicide Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source